BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33014187
Number of visits today
1592
Number of downloads
16204979
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Florczyk-Soluch U, Polak K, Dulak J. The multifaceted view of heart problem in Duchenne muscular dystrophy. Cell Mol Life Sci 2021;78:5447-68. [PMID: 34091693 DOI: 10.1007/s00018-021-03862-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Polak K, Stępniewski J, Ścieżyńska A, Podgórska A, Dulak J, Florczyk-Soluch U. Generation of human induced pluripotent stem cell lines with HMOX1 promoter polymorphism and CRISPR/Cas9-mediated deletion of exon 50 of DMD gene. Stem Cell Res 2023;66:103004. [PMID: 36565681 DOI: 10.1016/j.scr.2022.103004] [Reference Citation Analysis]
2 Kracht KD, Eichorn NL, Berlau DJ. Perspectives on the advances in the pharmacotherapeutic management of Duchenne muscular dystrophy. Expert Opin Pharmacother 2022. [PMID: 36168943 DOI: 10.1080/14656566.2022.2130246] [Reference Citation Analysis]
3 Du Y, Demillard LJ, Ren J. Sarcoplasmic Reticulum Ca2+ Dysregulation in the Pathophysiology of Inherited Arrhythmia: An Update. Biochemical Pharmacology 2022;200:115059. [DOI: 10.1016/j.bcp.2022.115059] [Reference Citation Analysis]
4 Migliore B, Zhou L, Duparc M, Robles V, Rehder C, Peay H, Kucera K. Evaluation of the GSP Creatine Kinase-MM Assay and Assessment of CK-MM Stability in Newborn, Patient, and Contrived Dried Blood Spots for Newborn Screening for Duchenne Muscular Dystrophy. IJNS 2022;8:12. [DOI: 10.3390/ijns8010012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jariwala P, Jadhav K, Khetan S. Effectiveness and Safety of Sacubitril/Valsartan for Heart Failure with Reduced Ejection Fraction Secondary to Duchenne Muscular Dystrophy-Associated Cardiomyopathy. J Indian Acad Echocardiogr Cardiovasc Imaging 2022;0:0. [DOI: 10.4103/jiae.jiae_17_22] [Reference Citation Analysis]
6 Kaziród K, Myszka M, Dulak J, Łoboda A. Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases. Cell Mol Life Sci 2022;79:608. [PMID: 36441348 DOI: 10.1007/s00018-022-04636-0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345